Daily pill for lung cancer to be made routinely available on the NHS

Daily pill for lung cancer to be made routinely available on the NHS

Dorking Leatherhead Advertiser

Published

The drug, Osimertinib—also known by its brand name Tagrisso and produced by AstraZeneca— which increases survival time post-surgery will now join the list of medicines routinely offered by the NHS.

Full Article